FDA Inspection 764424 — Carter BloodCare - Tyler

Carter BloodCare - Tyler — FEI 1672331

The FDA completed an inspection of Carter BloodCare - Tyler on January 20, 2012 in Tyler, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 20, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Tyler, TX (United States)